LPCN
Lipocine
$2.14
+$0.06 (+2.88%)Jul 27, 2026
Key metrics
The numbers that frame LPCN today
- Market cap
- $17.64M
- P/E (TTM)
- -1.5
- EV / FCF
- -1.3
- Gross margin
- 100%
- EV / Sales
- 6.3
- ROIC
- -94.5%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $1.81
- 52wk High
- $12.37
Growth
Revenue and earnings trend for LPCN
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about LPCN
Is Lipocine a good buy?
No. Lipocine has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks mixed. The support signal is useful, but not decisive. We think Lipocine is selling at a very high price.
What is the market capitalization of LPCN?
Lipocine's market capitalization is $17.64M.
What is the P/E ratio for LPCN stock?
Lipocine's current P/E ratio is -1.5.
What is the 52-week high for LPCN stock?
The 52-week high for Lipocine is $12.37. The current close of $2.14 is 82.7% below that high.
What is the 52-week low for LPCN stock?
The 52-week low for Lipocine is $1.81. The current close of $2.14 is 18.2% above that low.
Does LPCN stock pay dividends?
Lipocine does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for LPCN?
Lipocine's Debt / Equity ratio is 0.